Hemophilic arthropathy in patients with von Willebrand disease

Blood Reviews

Volumn 26, Issue 6, 2012, Pages 261-266

  van Galen, K P M ^a   Mauser Bunschoten, E P ^a   Leebeek, F W G ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Arthropathy; Joint bleed; Von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 PLUS VON WILLEBRAND FACTOR; DESMOPRESSIN; HYDROXYAPATITE; YTTRIUM 90;

AGE; ARTICLE; DISEASE SEVERITY; HEMOPHILIC ARTHROPATHY; HUMAN; JOINT RADIOGRAPHY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN NECROSIS; SYNOVECTOMY; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

HEMORRHAGE; HUMANS; JOINT DISEASES; JOINTS; VON WILLEBRAND DISEASES;

EID: 84868194145     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2012.09.002     Document Type: Article

References (54)

1. Rodeghiero F., Castaman G., Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987, 69:454-459.
2. Lak M., Peyvandi F., Mannucci P.M. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol 2000, 111:1236-1239.
3. De Wee E.M., Sanders Y.V., Mauser-Bunschoten E.P., van der Bom J.G., Degenaar-Dujardin M.E., Eikenboom J., et al. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease. Thromb Haemost 2012, 108(4). (Aug. 23).
4. Jansen N.W., Roosendaal G., Lafeber F.P. Understanding haemophilic arthropathy: an exploration of current open issues. Br J Haematol 2008, 143:632-640.
5. Raffini L., Manno C. Modern management of haemophilic arthropathy. Br J Haematol 2007, 136:777-787.
6. Hooiveld M., Roosendaal G., Vianen M., van den B.M., Bijlsma J., Lafeber F. Blood-induced joint damage: longterm effects in vitro and in vivo. J Rheumatol 2003, 30:339-344.
7. Manco-Johnson M.J., Abshire T.C., Shapiro A.D., Riske B., Hacker M.R., Kilcoyne R., et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007, 357:535-544.
8. Macfarlane J.D., Kroon H.M., Caekebeke-Peerlinck K.M. Arthropathy in von Willebrand's disease. Clin Rheumatol 1989, 8:98-102.
9. von Silwer J. Willebrand's disease in Sweden. Acta Paediatr Scand Suppl 1973, 238:1-159.
10. Woods A.I., Meschengieser S.S., Blanco A.N., Salviu M.J., Farias C.E., Kempfer A.C., et al. Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease. Haematologica 2001, 86:420-427.
11. Federici A.B. Clinical diagnosis of von Willebrand disease. Haemophilia 2004, 10(Suppl. 4):169-176.
12. Sumner M., Williams J. Type 3 von Willebrand disease: assessment of complications and approaches to treatment-results of a patient and Hemophilia Treatment Center Survey in the United States. Haemophilia 2004, 10:360-366.
13. Zhang L., Li H., Zhao H., Zhang X., Ji L., Yang R. Retrospective analysis of 1312 patients with haemophilia and related disorders in a single Chinese institute. Haemophilia 2003, 9:696-702.
14. Ziv O., Ragni M.V. Bleeding manifestations in males with von Willebrand disease. Haemophilia 2004, 10:162-168.
15. Lusher J.M., McMillan C.W. Severe factor VIII and factor IX deficiency in females. Am J Med 1978, 65:637-648.
16. Ahlberg A., Silwer J. Arthropathy in von Willebrand's disease. Acta Orthop Scand 1970, 41:539-544.
17. Choiniere M., Melzack R. Acute and chronic pain in hemophilia. Pain 1987, 31:317-331.
18. Soucie J.M., Wang C., Forsyth A., Funk S., Denny M., Roach K.E., et al. Range of motion measurements: reference values and a database for comparison studies. Haemophilia 2011, 17:500-507.
19. Metjian A.D., Wang C., Sood S.L., Cuker A., Peterson S.M., Soucie J.M., et al. Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia 2009, 15:918-925.
20. Abshire T. The role of prophylaxis in the management of von Willebrand disease: today and tomorrow. Thromb Res 2009, 124(Suppl. 1):S15-S19.
21. Kirtava A., Drews C., Lally C., Dilley A., Evatt B. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia 2003, 9:292-297.
22. Solovieva S. Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia 2001, 7:53-63.
23. Barr R.D., Saleh M., Furlong W., Horsman J., Sek J., Pai M., et al. Health status and health-related quality of life associated with hemophilia. Am J Hematol 2002, 71:152-160.
24. de Wee E.M., Mauser-Bunschoten E.P., van der Bom J.G., genaar-Dujardin M.E., Eikenboom H.C., Fijnvandraat K., et al. Health-related quality of life among adult patients with moderate and severe von Willebrand disease. J Thromb Haemost 2010, 8:1492-1499.
25. de Wee E.M., Fijnvandraat K., de Goede-Bolder A., Mauser-Bunschoten E.P., Eikenboom J.C., Brons P.P., et al. Impact of von Willebrand disease on health-related quality of life in a pediatric population. J Thromb Haemost 2011, 9:502-509.
26. Barr R.D., Sek J., Horsman J., Furlong W., Saleh M., Pai M., et al. Health status and health-related quality of life associated with von Willebrand disease. Am J Hematol 2003, 73:108-114.
27. Hovy L. Joint preserving operations and endoprosthetic joint substitutions in hemophiliacs. Indications and long term results. Orthopade 1999, 28:356-365.
28. Panotopoulos J., Trieb K. Orthopedic interventions in patients with hemophilia. Wien Med Wochenschr 2003, 153:225-231.
29. Kurth A.A., Ludwig G., Scharrer I. Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients. Orthopade 1999, 28:366-374.
30. Berntorp E. Prophylaxis in von Willebrand disease. Haemophilia 2008, 14(Suppl. 5):47-53.
31. Lethagen S. Clinical experience of prophylactic treatment in von Willebrand disease. Thromb Res 2006, 118(Suppl. 1):S9-S11.
32. Berntorp E., Abshire T. The von Willebrand disease prophylaxis network: exploring a treatment concept. J Thromb Haemost 2006, 4:2511-2512.
33. Berntorp E., De M P., Ljung R.C. The role of prophylaxis in bleeding disorders. Haemophilia 2010, 16(Suppl. 5):189-193.
34. Abshire T.C., Federici A.B., Alvarez M.T., Bowen J., Carcao M.D., Cox G.J., et al. Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN). Haemophilia Jul 23. 2012, [Epub ahead of print].
35. Federici A.B. Highly purified VWF/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO. WILL Study. Haemophilia 2007, 13(Suppl. 5):15-24.
36. Halimeh S., Krumpel A., Rott H., Bogdanova N., Budde U., Manner D., et al. Long-term secondary prophylaxis in children, adolescents and young adults with von Willebrand disease. Results of a cohort study. Thromb Haemost 2011, 105:597-604.
37. Manco-Johnson M.J., Nuss R., Funk S., Murphy J. Joint evaluation instruments for children and adults with haemophilia. Haemophilia 2000, 6:649-657.
38. Hilliard P., Funk S., Zourikian N., Bergstrom B.M., Bradley C.S., McLimont M., et al. Hemophilia joint health score reliability study. Haemophilia 2006, 12:518-525.
39. van Genderen F.R., Westers P., Heijnen L., de Kleijn P, van den Berg H.M., Helders P.J., et al. Measuring patients' perceptions on their functional abilities: validation of the Haemophilia Activities List. Haemophilia 2006, 12:36-46.
40. Cardol M., de Haan R.J., van den Bos G.A., de Jong B.A., de G IJ The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA). Clin Rehabil 1999, 13:411-419.
41. Melchiorre D., Linari S., Innocenti M., Biscoglio I., Toigo M., Cerinic M.M., et al. Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score. Haemophilia 2011, 17:112-117.
42. Klukowska A., Czyrny Z., Laguna P., Brzewski M., Serafin-Krol M.A., Rokicka-Milewska R. Correlation between clinical, radiological and ultrasonographical image of knee joints in children with haemophilia. Haemophilia 2001, 7:286-292.
43. Doria A.S. State-of-the-art imaging techniques for the evaluation of haemophilic arthropathy: present and future. Haemophilia 2010, 16(Suppl. 5):107-114.
44. Molho P., Verrier P., Stieltjes N., Schacher J.M., Ounnoughene N., Vassilieff D., et al. A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosis. Haemophilia 1999, 5:115-123.
45. Rivard G.E., Girard M., Belanger R., Jutras M., Guay J.P., Marton D. Synoviorthesis with colloidal 32P chromic phosphate for the treatment of hemophilic arthropathy. J Bone Joint Surg Am 1994, 76:482-488.
46. Kamineni S., Adams R.A., O'Driscoll S.W., Morrey B.F. Hemophilic arthropathy of the elbow treated by total elbow replacement. A case series. J Bone Joint Surg Am 2004, 86-A:584-589.
47. Habermann B., Eberhardt C., Hovy L., Zichner L., Scharrer I., Kurth A.A. Total hip replacement in patients with severe bleeding disorders. A 30 years single center experience. Int Orthop 2007, 31:17-21.
48. Duthie R.B. Reconstructive surgery in hemophilia. Ann N Y Acad Sci 1975, 240:295-310.
49. Butler-Manuel P.A., Smith M.A., Savidge G.F. Silastic interposition for haemophilic arthropathy of the elbow. J Bone Joint Surg Br 1990, 72:472-474.
50. Meskal A., Vertessen F., Van der Planken M., Berneman Z.N. The platelet function analyzer (PFA-100) may not be suitable for monitoring the therapeutic efficiency of von Willebrand concentrate in type III von Willebrand disease. Ann Hematol 1999, 78:426-430.
51. Luck J.V., Kasper C.K. Surgical management of advanced hemophilic arthropathy. An overview of 20 years' experience. Clin Orthop Relat Res 1989, 60-82.
52. Thomas S., Gabriel M.C., De Souza S.A.L., Gomes S.C., Assi P.E., Perri M.L.P., et al. (90)Yttrium-hydroxyapatite: a new therapeutic option for radioactive synovectomy in haemophilic synovitis. Haemophilia 2011, 17:E985-E989.
53. Thomas S., Gabriel M.B., Assi P.E., Barboza M., Perri M.L.P., Land M.G.P., et al. Radioactive synovectomy with Yttrium(90) citrate in haemophilic synovitis: Brazilian experience. Haemophilia 2011, 17:E211-E216.
54. Panotopoulos J., Hanslik-Schnabel B., Wanivenhaus A., Trieb K. Outcome of surgical concepts in haemophilic arthropathy of the hindfoot. Haemophilia 2005, 11:468-471.